Hawk70 you haven’t answered me why is AGN at a 100 million market cap on pre clinical results? And apparently they need to wait 10 years phase 2 but started it within 3 months after phase 1 so what’s going on? Please explain in detail ?
Also NYR are 12 months behind AGN in development of the drug but NYR has the US Army on top of that
NYR - 10 million in funding and 10 million market cap AGN - 100 million market cap and 20 million in funding
GLP results coming up which are already de risked and then we move into phase 1 and Walter reed which is derisked from 2012 pre clinical study then FDA submission in Feb and then phase 2 with funding from the US defence force.
100 million market cap is coming in and filling my final accumulation. 10 million market cap and 10 million in funding funny
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)